POLYETHYLENE GLYCOL, UNSPECIFIED

POLYETHYLENE GLYCOL, UNSPECIFIED was reported 100 times

POLYETHYLENE GLYCOL, UNSPECIFIED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EOSINOPHIL COUNT NORMAL 1 0.0714
1 PHOSPHOLIPIDOSIS 2 0.0202
2 HOME CARE 1 0.0156
3 MESENTERIC HAEMORRHAGE 1 0.0116
4 SOMATIC DYSFUNCTION 1 0.0111
5 AMINO ACID LEVEL ABNORMAL 1 0.0103
6 ANTACID THERAPY 1 0.0077
7 VENTRICULAR ASYSTOLE 1 0.0057
8 MUSCULOSKELETAL TOXICITY 1 0.0054
9 CYSTITIS RADIATION 1 0.0052
10 SLEEP DISORDER THERAPY 1 0.0051
11 MALIGNANT MELANOMA STAGE 0 1 0.0048
12 CONGENITAL HIATUS HERNIA 1 0.0044
13 PNEUMOTHORAX TRAUMATIC 1 0.0041
14 BACTEROIDES INFECTION 1 0.0038
15 ANTICOAGULANT THERAPY 1 0.0035
16 ANALGESIC THERAPY 1 0.0031
17 CANDIDA PNEUMONIA 1 0.0031
18 DRUG THERAPY 1 0.0029
19 AMYOTROPHY 1 0.0026
20 APPENDICOLITH 1 0.0026
21 URETHRAL OBSTRUCTION 1 0.0025
22 RED BLOOD CELL TRANSFUSION 1 0.0024
23 SINUS RHYTHM 1 0.0023
24 MITOCHONDRIAL CYTOPATHY 1 0.0023
25 BONE DEMINERALISATION 2 0.0019
26 POSTOPERATIVE ILEUS 1 0.0018
27 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
28 TOOTH EROSION 1 0.0008
29 PLATELET TRANSFUSION 1 0.0008
30 ECHOCARDIOGRAM ABNORMAL 1 0.0007
31 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
32 TONIC CONVULSION 1 0.0007
33 TOTAL LUNG CAPACITY DECREASED 1 0.0006
34 SHOULDER FRACTURE 1 0.0006
35 APLASTIC ANAEMIA 3 0.0006
36 AORTIC STENOSIS 2 0.0006
37 UNDERWEIGHT 1 0.0005
38 HYPERPHOSPHATAEMIA 1 0.0005
39 CLOSTRIDIUM TEST POSITIVE 1 0.0005
40 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
41 PERIARTHRITIS 1 0.0004
42 ORAL PRURITUS 1 0.0004
43 METASTATIC MALIGNANT MELANOMA 1 0.0004
44 REACTION TO EXCIPIENT 1 0.0004
45 VOLVULUS 1 0.0004
46 CARDIOMYOPATHY 6 0.0004
47 LUNG OPACITY 1 0.0004
48 BLOOD PHOSPHORUS INCREASED 1 0.0004
49 PLEURITIC PAIN 1 0.0004
50 RESPIRATORY SYMPTOM 1 0.0004
51 PHARMACEUTICAL PRODUCT COMPLAINT 9 0.0003
52 MASTICATION DISORDER 1 0.0003
53 EOSINOPHILIC PNEUMONIA 1 0.0003
54 VENTRICULAR ARRHYTHMIA 1 0.0003
55 MYASTHENIA GRAVIS 2 0.0002
56 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 1 0.0002
57 ABSCESS LIMB 1 0.0002
58 CARDIAC FAILURE CHRONIC 1 0.0002
59 IRON DEFICIENCY 1 0.0002
60 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
61 LUMBAR VERTEBRAL FRACTURE 1 0.0002
62 BREATH SOUNDS ABNORMAL 1 0.0002
63 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
64 PETIT MAL EPILEPSY 1 0.0002
65 CACHEXIA 1 0.0002
66 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
67 FAILURE TO THRIVE 1 0.0002
68 VENTRICULAR EXTRASYSTOLES 2 0.0002
69 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
70 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
71 ASPIRATION 2 0.0002
72 CARDIAC VALVE DISEASE 1 0.0002
73 BLOOD URIC ACID INCREASED 1 0.0002
74 RALES 1 0.0002
75 OLIGURIA 1 0.0002
76 SOMNAMBULISM 1 0.0002
77 MENINGITIS 1 0.0001
78 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
79 QUALITY OF LIFE DECREASED 2 0.0001
80 BRONCHIECTASIS 1 0.0001
81 BLOOD TEST ABNORMAL 2 0.0001
82 HYPOPHOSPHATAEMIA 1 0.0001
83 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
84 TROPONIN INCREASED 1 0.0001
85 BOWEL MOVEMENT IRREGULARITY 1 0.0001
86 ATRIOVENTRICULAR BLOCK 1 0.0001
87 CONCUSSION 1 0.0001
88 PELVIC FRACTURE 1 0.0001
89 TORSADE DE POINTES 1 0.0001
90 TRICUSPID VALVE INCOMPETENCE 1 0.0001
91 SUBSTANCE ABUSE 1 0.0001
92 SPINAL COMPRESSION FRACTURE 1 0.0001
93 ACUTE CORONARY SYNDROME 1 0.0001
94 SKIN HYPERPIGMENTATION 1 0.0001
95 MYOPATHY 1 0.0001
96 MUCOSAL INFLAMMATION 3 0.0001
97 ANHEDONIA 3 0.0001
98 BLOOD CALCIUM INCREASED 1 0.0001
99 TUMOUR LYSIS SYNDROME 1 0.0001
100 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
101 MYOSITIS 1 0.0001
102 ANAL INCONTINENCE 1 0.0001
103 APPENDICITIS 1 0.0001
104 SPUTUM DISCOLOURED 1 0.0001
105 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
106 HYPERCHOLESTEROLAEMIA 1 0.0001
107 EYELID PTOSIS 1 0.0001
108 OSTEOPOROSIS 4 0.0001
109 TRANSFUSION 1 0.0001
110 FULL BLOOD COUNT ABNORMAL 1 0.0001
111 JOINT INJURY 2 0.0001
112 DECREASED ACTIVITY 1 0.0001
113 DENTAL CARIES 1 0.0001
114 VENTRICULAR FIBRILLATION 1 0.0001
115 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
116 MICTURITION URGENCY 1 0.0001
117 MYOCARDITIS 1 0.0001
118 MACULAR DEGENERATION 1 0.0001
119 HYPERLIPIDAEMIA 1 0.0001
120 RESPIRATORY DEPRESSION 1 0.0001
121 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
122 SMALL INTESTINAL OBSTRUCTION 1 0.0001
123 IMPAIRED GASTRIC EMPTYING 1 0.0001
124 DIALYSIS 1 0.0001
125 CARDIOGENIC SHOCK 1 0.0001
126 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
127 PULMONARY MASS 1 0.0001
128 ECONOMIC PROBLEM 1 0.0001
129 OSTEOPENIA 1 0.0001
130 DRUG-INDUCED LIVER INJURY 2 0.0001
131 ULCER 1 0.0001
132 CARDIAC FAILURE CONGESTIVE 5 0.0001
133 VENTRICULAR TACHYCARDIA 1 0.0001
134 FEBRILE NEUTROPENIA 4 0.0001
135 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
136 DEVICE DEFECTIVE 1 0.0001
137 ORTHOSTATIC HYPOTENSION 1 0.0001
138 BRADYCARDIA 3 0.0001
139 GOUT 1 0.0001
140 LEUKOCYTOSIS 1 0.0001
141 RESTLESS LEGS SYNDROME 1 0.0001
142 END STAGE RENAL DISEASE 1 0.0001
143 BACTERIAL INFECTION 1 0.0001
144 COLITIS 2 0.0001
145 PULMONARY FIBROSIS 1 0.0001
146 ACUTE RESPIRATORY FAILURE 1 0.0001
147 HAEMORRHOIDS 1 0.0001
148 FEEDING DISORDER 1 0.0000
149 PRODUCT PREPARATION ERROR 1 0.0000
150 RIB FRACTURE 1 0.0000
151 TOOTH LOSS 1 0.0000
152 EATING DISORDER 1 0.0000
153 LIVER FUNCTION TEST INCREASED 1 0.0000
154 SKIN CANCER 1 0.0000
155 PRURITUS GENERALISED 1 0.0000
156 TRANSAMINASES INCREASED 1 0.0000
157 PRODUCT AVAILABILITY ISSUE 1 0.0000
158 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
159 PRODUCT PRESCRIBING ERROR 1 0.0000
160 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
161 NEURALGIA 1 0.0000
162 DYSGEUSIA 3 0.0000
163 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
164 ABDOMINAL PAIN LOWER 1 0.0000
165 CARDIOVASCULAR DISORDER 1 0.0000
166 SEDATION 1 0.0000
167 MENTAL STATUS CHANGES 1 0.0000
168 HAEMOPTYSIS 1 0.0000
169 HYPONATRAEMIA 2 0.0000
170 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
171 FLATULENCE 2 0.0000
172 SEIZURE 4 0.0000
173 DYSSTASIA 1 0.0000
174 ASCITES 1 0.0000
175 RESPIRATORY DISORDER 1 0.0000
176 CORONARY ARTERY DISEASE 1 0.0000
177 HYPOTHYROIDISM 1 0.0000
178 METABOLIC ACIDOSIS 1 0.0000
179 DRUG INTOLERANCE 3 0.0000
180 BLOOD CREATININE INCREASED 2 0.0000
181 OSTEONECROSIS 1 0.0000
182 STAPHYLOCOCCAL INFECTION 1 0.0000
183 GAIT INABILITY 1 0.0000
184 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
185 HAEMATURIA 1 0.0000
186 DELIRIUM 1 0.0000
187 HYPOXIA 1 0.0000
188 SLEEP DISORDER 2 0.0000
189 THERAPY INTERRUPTED 2 0.0000
190 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
191 PANIC ATTACK 1 0.0000
192 RESPIRATORY FAILURE 2 0.0000
193 ACCIDENTAL OVERDOSE 1 0.0000
194 SEPSIS 3 0.0000
195 THROMBOCYTOPENIA 3 0.0000
196 EMOTIONAL DISTRESS 3 0.0000
197 DYSKINESIA 1 0.0000
198 ROAD TRAFFIC ACCIDENT 1 0.0000
199 OSTEOARTHRITIS 1 0.0000
200 HYPOACUSIS 1 0.0000
201 MENTAL DISORDER 1 0.0000
202 CONSTIPATION 5 0.0000
203 MUSCULOSKELETAL STIFFNESS 2 0.0000
204 GASTROINTESTINAL DISORDER 2 0.0000
205 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
206 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
207 ADVERSE EVENT 2 0.0000
208 BLOOD CHOLESTEROL INCREASED 1 0.0000
209 NEUROPATHY PERIPHERAL 2 0.0000
210 COMA 1 0.0000
211 LUNG DISORDER 1 0.0000
212 ACUTE KIDNEY INJURY 3 0.0000
213 THERAPY CESSATION 1 0.0000
214 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
215 ABDOMINAL DISTENSION 2 0.0000
216 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
217 OVERDOSE 4 0.0000
218 TREATMENT NONCOMPLIANCE 1 0.0000
219 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
220 BLISTER 1 0.0000
221 TOXICITY TO VARIOUS AGENTS 3 0.0000
222 MUSCULAR WEAKNESS 2 0.0000
223 CONVULSION 1 0.0000
224 PALPITATIONS 2 0.0000
225 BONE PAIN 1 0.0000
226 DISEASE PROGRESSION 2 0.0000
227 WHEEZING 1 0.0000
228 PLEURAL EFFUSION 1 0.0000
229 AMNESIA 1 0.0000
230 RENAL FAILURE 2 0.0000
231 ABDOMINAL PAIN UPPER 3 0.0000
232 INJURY 1 0.0000
233 HYPERTENSION 3 0.0000
234 MOBILITY DECREASED 1 0.0000
235 PRODUCT DOSE OMISSION ISSUE 4 0.0000
236 ASTHENIA 5 0.0000
237 DIABETES MELLITUS 1 0.0000
238 ABDOMINAL PAIN 3 0.0000
239 VOMITING 6 0.0000
240 DRUG INTERACTION 2 0.0000
241 OFF LABEL USE 11 0.0000
242 CARDIAC FAILURE 1 0.0000
243 THROMBOSIS 1 0.0000
244 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
245 DRY MOUTH 1 0.0000
246 CARDIAC ARREST 1 0.0000
247 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
248 TREATMENT FAILURE 1 0.0000
249 DRUG ABUSE 1 0.0000
250 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
251 ABDOMINAL DISCOMFORT 2 0.0000
252 RENAL IMPAIRMENT 1 0.0000
253 BALANCE DISORDER 1 0.0000
254 INTENTIONAL PRODUCT MISUSE 1 0.0000
255 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
256 DRUG WITHDRAWAL SYNDROME 1 0.0000
257 DEVICE ISSUE 1 0.0000
258 DIARRHOEA 7 0.0000
259 CHEST PAIN 2 0.0000
260 SWELLING 1 0.0000
261 PRODUCT USE ISSUE 2 0.0000
262 ANXIETY 3 0.0000
263 PULMONARY EMBOLISM 1 0.0000
264 ANAEMIA 2 0.0000
265 PAIN IN EXTREMITY 3 0.0000
266 SYNCOPE 1 0.0000
267 SOMNOLENCE 2 0.0000
268 CONDITION AGGRAVATED 3 0.0000
269 PAIN 6 0.0000
270 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
271 ILLNESS 1 0.0000
272 ASTHMA 1 0.0000
273 NAUSEA 7 0.0000
274 PYREXIA 3 0.0000
275 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
276 DRUG INEFFECTIVE 11 0.0000
277 OEDEMA PERIPHERAL 1 0.0000
278 VISUAL IMPAIRMENT 1 0.0000
279 HEADACHE 5 0.0000
280 LOSS OF CONSCIOUSNESS 1 0.0000
281 HYPERHIDROSIS 1 0.0000
282 DEHYDRATION 1 0.0000
283 NEUTROPENIA 1 0.0000
284 VISION BLURRED 1 0.0000
285 MEMORY IMPAIRMENT 1 0.0000
286 HYPOAESTHESIA 1 0.0000
287 BLOOD PRESSURE INCREASED 1 0.0000
288 HOSPITALISATION 1 0.0000
289 PERIPHERAL SWELLING 1 0.0000
290 DRUG DEPENDENCE 1 0.0000
291 CONFUSIONAL STATE 1 0.0000
292 TREMOR 1 0.0000
293 CEREBROVASCULAR ACCIDENT 1 0.0000
294 COVID-19 1 0.0000
295 MUSCLE SPASMS 1 0.0000
296 BLOOD GLUCOSE INCREASED 1 0.0000
297 DYSPNOEA 3 0.0000
298 GAIT DISTURBANCE 1 0.0000
299 FATIGUE 4 0.0000
300 HYPOTENSION 1 0.0000
301 DEATH 4 0.0000
302 RASH 2 0.0000
303 MALAISE 2 0.0000
304 DEPRESSION 1 0.0000
305 INCORRECT DOSE ADMINISTERED 1 0.0000
306 DECREASED APPETITE 1 0.0000
307 BACK PAIN 1 0.0000
308 WEIGHT DECREASED 1 0.0000
309 COUGH 1 0.0000
310 PNEUMONIA 1 0.0000
311 FALL 1 0.0000
312 ARTHRALGIA 1 0.0000
313 DIZZINESS 1 0.0000